Generic Name and Formulations:
Dimenhydrinate 50mg; scored tabs.
McNeil Consumer Healthcare
Indications for DRAMAMINE:
Motion sickness prophylaxis.
50–100mg every 4–6 hours, starting ½–1 hour before travel; max 400mg/day.
<2 years: not recommended. 2–6 years: 12.5–25mg; max 75mg/day. 6–11 yrs: 25–50mg; max 150mg/day. Both: starting ½–1 hour before travel; may repeat every 6–8 hours.
Asthma or chronic respiratory disease. Glaucoma. Arrhythmias. GI or urinary obstruction. Phenylketonuria (chewable tabs). Pregnancy (Cat.B). Nursing mothers: not recommended.
Potentiates CNS depression with alcohol, other CNS depressants. May potentiate ototoxicity of antibiotics (esp. aminoglycosides).
Drowsiness, sedation, anticholinergic effects, paradoxical excitement in children.
Tabs—12, 36, 100
Endocrinology Advisor Articles
- GLP-1 Agonists Superior to DPP-4 Inhibitors for Reducing HbA1c, Weight in T2D
- Effect of HbA1c and Perioperative Glucose on Postoperative Mortality
- Semaglutide May Be Useful for Treating Obesity in People Without Diabetes
- Once-Daily Oral Contraceptive for Men Shows Promise
- Reducing Total Daily Insulin Dose in T2D: 3-Meal vs 6-Meal Diet
- American College of Physicians Releases 4 Guidelines for HbA1c Targets in T2D
- Dyslipidemia Drug Indications
- No Difference in Weight Loss Outcomes With Low-Fat vs Low-Carbohydrate Diet
- Damaging Effects of Gastric Bypass Surgery on Bone Mass and Microarchitecture
- Gastric Bypass Surgery Linked to Increased Risk for Nonvertebral Fractures
- Effect of High Androgen Levels on Cardiovascular Risk in Postmenopausal Women
- Fertility in Women Negatively Affected by Asthma Medications
- Glucocorticoid Use in COPD Does Not Increase Fracture Risk
- Drug Copayments Often Cost More Than Prescription Drugs
- Closed-Loop Insulin Delivery Offers Best Outcomes for Pregnant Women With T1D